A study on free radical-induced renal toxicity due to cyclophosphamide and its amelioration with N-acetyl cysteine
Authors
-
,IN
K. Jyothi -
,INA. Gopala Reddy
-
,INGopi K. S.
-
,INB. Anil Kumar
-
,ING. Dilip Reddy
Keywords:
Cyclophosphamide (CYP), N-acetyl cysteine (NAC), Oxidative stressAbstract
A study was conducted to evaluate the protective effect of N-acetyl cysteine (NAC) against experimentally-induced renal toxicity due to cyclophosphamide (CYP) in rats. Three groups (2, 3 and 4) of female Wistar Kyoto rats with 6 animals in each group were administered with CYP @ 40 mg/kg bwt on 1st, 3rd, 5th and 7th day by intraperitoneal route. Group 2 remained as toxic control. Group 3 received NAC from 1st to 14th day @ 0.2% of feed and group 4 was treated with NAC from 8th to 14th day. Group 1 was maintained on basal diet for 14 days. The study revealed a significant (P < 0.05) increase in the concentration of serum creatinine, blood urea nitrogen, thiobarbituric acid reacting substances (TBARS) and protein carbonyls, and a decrease in the reduced glutathione (GSH) concentration of kidney. These results are suggestive of CYP-induced oxidative stress resulting in renal damage. Feeding of NAC could not offer protection against CYPinduced renal damage in this study.Downloads
Published
How to Cite
Issue
Section
References
Balasubramanian, KA, Manohar, M and Mathan, VI (1988). An unidentified inhibitor of lipid peroxidation in intestinal mucosa. Biochim Biophysic Acta, 962: 51-58.
Dekhuijzen, PNR (2004). Antioxidant properties of Nacetylcysteine: their relevance in relation to chronic
obstructive pulmonary disease. European Respiratory J., 23: 629-636.
Flora De S, Izzotti, A, D' Agostini, F and Balansky (2001). Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking – related end – points. Carcinogenisis, 22: 999 – 1013.
Georgia, JP, Dianne, C, Michael, B, Sally, L, Eric, W, Brian, H, Colin, JH and Roland, CW (2005). Role of hepatic cytochrome P450s in the pharmacokinetics and toxicity of cyclophosphamide: Studies with the hepatic cytochrome P450 reductase Null mouse. Cancer Res., 65: 4211-4217.
Henry, SF, Colvin, OM, Aisaka, K, Jim, P, Bossen, EH, Reimer, KA, Powell, JB, John H, Gross, SS, Roberto, L, Bigner, DD and Griffith, OW (1990). Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. Cancer Res., 50: 2455-2462.
Kondala, RA, John, J, Leonard, AH and Leonore, AH (2007). N-Acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Current Opinion in Pharmacol., 7: 355-359.
Levine, RL, Garland, D, Oliver, CN, Amici, A, Climent, I, Lenz, AG, Ahn, BW, Shaltiel, S and Stadtman, ER (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymol., 186: 464-478.
Moore, MJ (1991). Clinical Pharmacokinetics of cyclophosphamide. Clinical Pharmacokinetics, 20: 194-208.
Moron, MS, Depierre, JW and Mannervik, B (1979). Levels of glutathione, glutathione reductase and glutathione S transferase in rat lung and liver. Biochim Biophysic Acta, 582: 67-68.
Senthilkumar, S, Devaki, T, Manohar, BM and Babu, MS (2006). Effect of squalene on cyclophosphamideinduced toxicity. Clinica Chimica Acta, 364: 335-342.
Sudharsan, PT, Mythili, Y, Selvakumar and Varalakshmi, P (2006): Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats. Mol. Cell Biochem., 292: 39-44.
Tepel, M, van der Giet, M and Schwarzfeld, C (2000). Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. New Engl J, Med., 343: 180-184.
Zhang, S, Chai, FY, Yan, HGY and Harding, JJ (2008). Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vision, 14: 862-870.
